OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
98
Results
Show all
Save search
Copy query
Show results for
Unknown
(98)
Publication Date
Release Date
2025
(17)
2024
(15)
2022
(11)
2021
(10)
2023
(8)
2020
(6)
2012
(4)
2019
(3)
2015
(3)
2014
(3)
2013
(3)
2011
(3)
2009
(3)
2026
(2)
2018
(2)
2017
(2)
2010
(2)
2016
(1)
Previous
page
1 / 10
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
10
Next
page
Sort
by:
Relevance
Page size
10
An RCT of Virtual Reality Job Interview Training for Individuals With Serious Mental Illness in IPS Supported Employment.
Not available
S-EPMC9661916
|
biostudies-literature
Cite
Exome sequencing and genome-wide linkage analysis in 17 families illustrate the complex contribution of TTN truncating variants to dilated cardiomyopathy.
Not available
S-EPMC3815606
|
biostudies-literature
Cite
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
Not available
S-EPMC10346510
|
biostudies-literature
Cite
Refractive Error Change and Overminus Lens Therapy for Childhood Intermittent Exotropia.
Not available
S-EPMC10958385
|
biostudies-literature
Cite
Extended Caffeine for Apnea in Moderately Preterm Infants: The MoCHA Randomized Clinical Trial.
Not available
S-EPMC12038711
|
biostudies-literature
Cite
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age.
Not available
S-EPMC9634866
|
biostudies-literature
Cite
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219
|
biostudies-literature
Cite
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.
Not available
S-EPMC8189635
|
biostudies-literature
Cite
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Not available
S-EPMC10824389
|
biostudies-literature
Cite
Choice of Dose Level for a Randomized Clinical Trial of Low-Dose Bevacizumab vs Laser for Type 1 Retinopathy of Prematurity.
Not available
S-EPMC8377606
|
biostudies-literature
Cite
Previous
page
1 / 10
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
10
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets